Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $250,004 | 21 | 100.0% |
| Food and Beverage | $104.74 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $249,390 | 20 | $0 (2021) |
| Ipsen Innovation | $614.25 | 1 | $0 (2020) |
| CSL Behring | $104.74 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $18,360 | 5 | AstraZeneca Pharmaceuticals LP ($18,360) |
| 2020 | $53,654 | 3 | AstraZeneca Pharmaceuticals LP ($53,040) |
| 2019 | $177,990 | 13 | AstraZeneca Pharmaceuticals LP ($177,990) |
| 2017 | $104.74 | 6 | CSL Behring ($104.74) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2021 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $3,060.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2021 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $4,080.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2021 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $5,100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2021 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $5,610.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $510.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/20/2020 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $6,120.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/24/2020 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $46,920.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2020 | Ipsen Innovation | — | Consulting Fee | Cash or cash equivalent | $614.25 | General |
| 11/17/2019 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| 11/11/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $28,560.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2019 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 10/15/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $22,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $14,280.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $9,690.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $7,140.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $13,260.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2019 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $20,910.00 | General |
| 05/20/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $7,650.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $29,580.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/24/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $12,240.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2019 | AstraZeneca Pharmaceuticals LP | CRESTOR (Drug) | Consulting Fee | Cash or cash equivalent | $7,140.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2017 | CSL Behring | — | Food and Beverage | In-kind items and services | $22.86 | General |
| 12/12/2017 | CSL Behring | — | Food and Beverage | In-kind items and services | $17.36 | General |
| 12/12/2017 | CSL Behring | — | Food and Beverage | In-kind items and services | $12.17 | General |
| 12/12/2017 | CSL Behring | — | Food and Beverage | In-kind items and services | $5.48 | General |
About Dr. Joel Raichlen, M.D
Dr. Joel Raichlen, M.D is a Cardiovascular Disease healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1588842835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Raichlen, M.D has received a total of $250,109 in payments from pharmaceutical and medical device companies, with $18,360 received in 2021. These payments were reported across 27 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($250,004).
Practice Information
- Specialty Cardiovascular Disease
- Location Bryn Mawr, PA
- Active Since 02/07/2008
- Last Updated 02/07/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588842835
Products in Payments
- CRESTOR (Drug) $223,890
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bryn Mawr
Dr. Sarang Mangalmurti, Md, MD
Cardiovascular Disease — Payments: $763,981
Sheetal Chandhok, Md, MD
Cardiovascular Disease — Payments: $293,988
Svetlana Nikitina, Md, MD
Cardiovascular Disease — Payments: $28,560
Glenn Harper, Md, MD
Cardiovascular Disease — Payments: $28,453
Jack Martin, M.d, M.D
Cardiovascular Disease — Payments: $25,627
Lawrence Mendelson, Md, MD
Cardiovascular Disease — Payments: $16,328